Cardiovascular risk factors associated with clinically isolated and diffuse atherosclerosis in Spanish patients with

J F Meco1, X Pintó, J M Escribà

  • 1Bellvitge Hospital, Barcelona, Spain.

Insights

Diffuse atherosclerosis, common in older patients, is linked to hypertension and diabetes. This condition, involving coronary, peripheral, and cerebrovascular disease, increases mortality risk.

Area of Science:

  • Cardiovascular Medicine
  • Atherosclerosis Research
  • Public Health

Background:

  • Patients with coronary artery disease (CAD) and associated peripheral (PAD) or cerebrovascular disease (CVD) have diffuse atherosclerosis, posing a higher mortality risk than isolated CAD.
  • The prevalence and risk factors of diffuse atherosclerosis in specific geographic regions remain underexplored.

Purpose of the Study:

  • To determine the prevalence of diffuse atherosclerosis in patients admitted for acute coronary syndromes.
  • To identify atherogenic risk factors associated with diffuse atherosclerosis in this patient cohort.

Main Methods:

  • A cohort of 2597 patients admitted for acute coronary syndromes were analyzed.
  • Patients were categorized into diffuse atherosclerosis (with PAD or CVD) and isolated CAD groups.
  • Baseline history, physical data, and lipid profiles were collected.

Main Results:

  • 14.2% of patients (370) exhibited diffuse atherosclerosis.
  • Diffuse atherosclerosis patients were older, more frequently hypertensive, diabetic, and former smokers.
  • Key risk factors identified included age >55, hypertension, diabetes, former smoking status, and a low HDL-C/TC ratio.

Conclusions:

  • Clinically evident diffuse atherosclerosis is a significant condition, affecting a notable portion of cardiovascular patients.
  • Older age, hypertension, diabetes, and a low HDL-C/TC ratio are strongly associated with diffuse atherosclerosis.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...